Staging Procedures to Diagnose Malignant Pleural Mesothelioma
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/8/2019 |
| Start Date: | March 14, 2016 |
| End Date: | December 2020 |
| Contact: | Karlyn Pierson, RN |
| Email: | pierson.karlyn@mayo.edu |
| Phone: | 507-293-0807 |
The purpose of this study is to evaluate the accuracy of participants imaging versus staging
procedures. The investigators will consent subjects that are scheduled to undergo staging
procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy,
endobronchial ultrasound and laparoscopy) as part of their standard of care.
procedures. The investigators will consent subjects that are scheduled to undergo staging
procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy,
endobronchial ultrasound and laparoscopy) as part of their standard of care.
Inclusion Criteria:
- Subject provides informed consent
- Subject is >18 years of age
- Subject is deemed competent for making medical decisions
- Subject is scheduled to undergo a staging pleuroscopy
- Subject is a surgical candidate
- A negative pregnancy test is required in women of child-bearing potential, as standard
of care.
Exclusion Criteria:
- Subject is <18 years old.
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Principal Investigator: Dennis A Wigle, MD, PhD
Phone: 507-538-1960
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
